A detailed history of Bank Of New Hampshire transactions in Embecta Corp. stock. As of the latest transaction made, Bank Of New Hampshire holds 1 shares of EMBC stock, worth $20. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1 -0.0%
Holding current value
$20
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 04, 2023

SELL
$23.07 - $32.77 $115 - $163
-5 Reduced 83.33%
1 $0
Q4 2022

Jan 10, 2023

SELL
$25.29 - $35.48 $1,517 - $2,128
-60 Reduced 90.91%
6 $1,000
Q3 2022

Oct 24, 2022

SELL
$24.0 - $33.42 $11,616 - $16,175
-484 Reduced 88.0%
66 $2,000
Q2 2022

Jul 08, 2022

BUY
$24.78 - $33.36 $13,629 - $18,348
550 New
550 $14,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Bank Of New Hampshire Portfolio

Follow Bank Of New Hampshire and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New Hampshire, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New Hampshire with notifications on news.